Q2 EPS Forecast for Century Therapeutics Reduced by Analyst

Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) – Leerink Partnrs cut their Q2 2025 earnings estimates for shares of Century Therapeutics in a research report issued on Monday, May 19th. Leerink Partnrs analyst D. Graybosch now expects that the company will post earnings per share of ($0.37) for the quarter, down from their previous forecast […]

May 23, 2025 - 07:00
 0
Q2 EPS Forecast for Century Therapeutics Reduced by Analyst
Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) – Leerink Partnrs cut their Q2 2025 earnings estimates for shares of Century Therapeutics in a research report issued on Monday, May 19th. Leerink Partnrs analyst D. Graybosch now expects that the company will post earnings per share of ($0.37) for the quarter, down from their previous forecast […]